JP2002536413A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002536413A5 JP2002536413A5 JP2000598162A JP2000598162A JP2002536413A5 JP 2002536413 A5 JP2002536413 A5 JP 2002536413A5 JP 2000598162 A JP2000598162 A JP 2000598162A JP 2000598162 A JP2000598162 A JP 2000598162A JP 2002536413 A5 JP2002536413 A5 JP 2002536413A5
- Authority
- JP
- Japan
- Prior art keywords
- guillain
- aminopyridine
- diabetes
- producing
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000016192 Demyelinating disease Diseases 0.000 description 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229960004979 fampridine Drugs 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11927399P | 1999-02-09 | 1999-02-09 | |
| US60/119,273 | 1999-02-09 | ||
| PCT/US2000/003396 WO2000047210A1 (en) | 1999-02-09 | 2000-02-09 | Use of 4-amino pyridine for treatment of peripheral neuropathies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002536413A JP2002536413A (ja) | 2002-10-29 |
| JP2002536413A5 true JP2002536413A5 (enExample) | 2007-04-05 |
Family
ID=22383494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000598162A Pending JP2002536413A (ja) | 1999-02-09 | 2000-02-09 | 末梢ニューロパシーの治療における４−アミノピリジンの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6503931B1 (enExample) |
| EP (1) | EP1152760B1 (enExample) |
| JP (1) | JP2002536413A (enExample) |
| AT (1) | ATE357914T1 (enExample) |
| AU (1) | AU3360000A (enExample) |
| CA (1) | CA2360326C (enExample) |
| DE (1) | DE60034110T2 (enExample) |
| DK (1) | DK1152760T3 (enExample) |
| ES (1) | ES2284485T3 (enExample) |
| WO (1) | WO2000047210A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2820423B1 (fr) * | 2001-02-05 | 2005-12-02 | Assist Publ Hopitaux De Paris | Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations |
| US20050192321A1 (en) * | 2003-09-15 | 2005-09-01 | Meythaler Jay M. | Treatment of neuropathy with rapid release aminopyridine |
| US10793893B2 (en) | 2011-06-30 | 2020-10-06 | Serb Sa | Methods of administering 3,4-diaminopyridine |
| TWI592156B (zh) * | 2011-10-04 | 2017-07-21 | 艾可達醫療公司 | 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法 |
| WO2014151752A1 (en) | 2013-03-15 | 2014-09-25 | University Of Rochester | Composition and methods for the treatment of peripheral nerve injury |
| MA35698B1 (fr) * | 2013-05-16 | 2014-12-01 | Univ Mohammed V Souissi | Nouvelle composition du 3,4-diaminopyridin pour le traitement de la fatigabilité musculaire associée à des troubles neurovégétatifs. |
| CN119698281A (zh) | 2022-07-08 | 2025-03-25 | 罗切斯特大学 | 用于预防、缓解和/或治疗毒性损害引起的组织功能障碍的钾通道阻滞剂或其衍生物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5221683A (en) * | 1984-03-19 | 1993-06-22 | The Rockefeller University | Diaminopyridine compounds and methods of use |
| US4855290A (en) * | 1985-05-10 | 1989-08-08 | State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research | Derivatives of quinuclidine |
| IE82916B1 (en) * | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| CA2085785C (en) * | 1992-12-18 | 2005-03-15 | Robert R. Hansebout | The use of 4-aminopyridine in the treatment of a neurological condition |
-
2000
- 2000-02-09 AU AU33600/00A patent/AU3360000A/en not_active Abandoned
- 2000-02-09 DE DE60034110T patent/DE60034110T2/de not_active Expired - Lifetime
- 2000-02-09 JP JP2000598162A patent/JP2002536413A/ja active Pending
- 2000-02-09 WO PCT/US2000/003396 patent/WO2000047210A1/en not_active Ceased
- 2000-02-09 CA CA2360326A patent/CA2360326C/en not_active Expired - Lifetime
- 2000-02-09 ES ES00911753T patent/ES2284485T3/es not_active Expired - Lifetime
- 2000-02-09 AT AT00911753T patent/ATE357914T1/de not_active IP Right Cessation
- 2000-02-09 EP EP00911753A patent/EP1152760B1/en not_active Expired - Lifetime
- 2000-02-09 US US09/913,082 patent/US6503931B1/en not_active Expired - Lifetime
- 2000-02-09 DK DK00911753T patent/DK1152760T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003503454A5 (enExample) | ||
| JP2004525194A5 (enExample) | ||
| MXPA03005155A (es) | 1,2-difenilazetidinonas novedosas, procesos para su preparacion, farmacos que contienen compuestos y su uso para el tratamiento del metabolismo afectado de los lipidos. | |
| AU2002337047A1 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
| HUP0401293A3 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
| ZA200200609B (en) | Process for producing phenyl-alkanes compositions produced thereform, and uses thereof. | |
| TWI315741B (en) | A-isomaltosyltransferase, process for producing the same and use thereof | |
| AU2402401A (en) | Polymerization catalyst for polyesters, polyesters produced with the same and process for producing polyesters | |
| EP1698329A4 (en) | PHARMACEUTICAL NANOTEILS, METHOD FOR THE PRODUCTION THEREOF AND PARENTERALLY APPLIED PRODUCT FROM NANOTEILES | |
| ZA200202521B (en) | 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preprations containing said compounds. | |
| AU2003242046A1 (en) | Sustained-release composition, process for producing the same and preparation thereof | |
| JP2002519182A5 (enExample) | ||
| WO2000058297A3 (en) | PROCESS FOR THE PREPARATION OF α-METHYLENE LACTONES | |
| AU2002363168A1 (en) | Heat-resistant filter layer, filter body and method for the production thereof | |
| WO2000067847A3 (de) | Verwendung von dopamin-d3-rezeptorliganden zur herstellung von arzneimittel für die behandlung von nierenfunktionsstörungen | |
| MXPA03009527A (es) | PROCEDIMIENTO PARA LA PREPARACIoN DE INDENOS 1,3-SUSTITUIDOS Y COMPUESTOS AZAPOLICICLICOS CONDENSADOS CON ARILO. | |
| ZA200302310B (en) | A process for preparing a catalyst, the catalyst and a use of the catalyst. | |
| WO2002030870A3 (de) | Substituierte c-cyclohexylmethylamin-derivate | |
| JP2002536413A5 (enExample) | ||
| HUP9602571A1 (en) | Reducted catalyst composition, using thereof and process for producing aldehydes and aldehyde-derivatives | |
| BR9805329B1 (pt) | catalisador, processo para a preparação o catalisador e processo para a preparação de acetato de vinila sob aplicação do catalisador. | |
| JP2004500380A5 (enExample) | ||
| MXPA03005516A (es) | Catalizador para la oxidacion de alcanos, proceso para la preparacion del mismo y proceso para producir un compuesto insaturado que contiene oxigeno. | |
| AU2003241785A1 (en) | Intravenous composition, process for producing the same and preparation thereof | |
| WO2001049651A3 (de) | Aminomethyl-phenyl-cyclohexanonderivate |